Consistent with this observation, it has been shown that KV2.1 pharmacological inhibition increases serum insulin levels, restores β cell mass, and decreases fasting blood glucose in a diabetes mouse model (43). This evidence concerns the gene KCNB1 and diabetes mellitus.